We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $87.3B Turnover 14.58%
1-Year Est. Return 22.01%
 

Cerity Partners is a wealth management firm, formerly called HPM Partners, that serves high net worth families, businesses and their employees, and nonprofits. HPM Partners took the new name in January 2019, a twist on the word sincerity. Besides managing investments, it offers financial planning, tax preparation and retirement plan consulting. It can also open private markets to clients through hedge funds and private equity funds. Employees own part of the firm through a holding company, alongside funds tied to private equity firm Genstar Capital. Genstar took a majority stake in a 2022 recapitalization.

This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+22.01%
3 Year Est. Return
+91.57%
5 Year Est. Return
+89.52%
10 Year Est. Return
+346.31%
AUM
$87.3B
AUM Growth
+$4.53B
Cap. Flow
+$2.46B
Cap. Flow %
2.82%
Top 10 Hldgs %
24.79%
Holding
3,711
New
307
Increased
1,756
Reduced
1,219
Closed
234
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.4 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
3 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.85%
2 Technology 19.41%
3 Financials 6.53%
4 Healthcare 5.9%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CCO icon
3376
DELISTED
Clear Channel Outdoor Holdings
CCO
$24.2K ﹤0.01%
10,303
-9,024
-47% -$21.6K
2025 Q3
4 quarters
POWW icon
3377
Outdoor Holding Co
POWW
$266M
$24.1K ﹤0.01%
10,701
-28,399
-73% -$63.6K
2026 Q2
1 quarter
CHRS icon
3378
Coherus Oncology
CHRS
$81.2M
$23.3K ﹤0.01%
19,262
-55,345
-74% -$75.7K
2024 Q3
8 quarters
CRSP icon
3379
CALL
CRISPR Therapeutics
CRSP
$4.1B
$22.1K ﹤0.01%
+400
New +$21.6K
2026 Q3
0 quarters
SMMT icon
3380
CALL
Summit Therapeutics
SMMT
$11.3B
$22K ﹤0.01%
+1,300
New +$19.4K
2026 Q3
0 quarters
PLYX icon
3381
Polaryx Therapeutics Inc
PLYX
$88.2M
$21.6K ﹤0.01%
+10,427
New +$22.7K
2026 Q3
0 quarters
AVD icon
3382
American Vanguard Corp
AVD
$25.9M
$21.5K ﹤0.01%
12,288
-8,988
-42% -$21.2K
2026 Q2
1 quarter
HAIN icon
3383
Hain Celestial
HAIN
$12.8M
$21.4K ﹤0.01%
43,788
-59,424
-58% -$35.4K
2024 Q2
9 quarters
KTOS icon
3384
CALL
Kratos Defense & Security Solutions
KTOS
$6.38B
$21.3K ﹤0.01%
+500
New +$25.5K
2026 Q3
0 quarters
HRTX icon
3385
Heron Therapeutics
HRTX
$59.1M
$20.6K ﹤0.01%
65,795
+5,454
+9% +$2.07K
2025 Q3
4 quarters
KLC icon
3386
KinderCare Learning Companies
KLC
$162M
$20.5K ﹤0.01%
11,005
-25,958
-70% -$96.7K
2025 Q4
3 quarters
LTH icon
3387
CALL
Life Time Group Holdings
LTH
$10.4B
$19.9K ﹤0.01%
+500
New +$21.3K
2026 Q3
0 quarters
OTLK icon
3388
Outlook Therapeutics
OTLK
$101M
$19.9K ﹤0.01%
+34,691
New +$33.1K
2026 Q3
0 quarters
SLB icon
3389
CALL
SLB Ltd
SLB
$76.3B
$19.5K ﹤0.01%
400
-400
-50% -$20.6K
2026 Q2
1 quarter
ALEC icon
3390
Alector
ALEC
$378M
$19.3K ﹤0.01%
10,454
-22,067
-68% -$42.6K
2025 Q1
6 quarters
LVS icon
3391
CALL
Las Vegas Sands
LVS
$25.3B
$18.9K ﹤0.01%
+500
New +$22.3K
2026 Q3
0 quarters
CRBU icon
3392
Caribou Biosciences
CRBU
$39.1M
$18.8K ﹤0.01%
+14,813
New +$23.1K
2026 Q3
0 quarters
VLN icon
3393
Valens Semiconductor
VLN
$158M
$18.8K ﹤0.01%
10,000
-7,500
-43% -$13.4K
2026 Q2
1 quarter
AKBA icon
3394
Akebia Therapeutics
AKBA
$132M
$18.6K ﹤0.01%
20,254
-91,863
-82% -$98.8K
2026 Q2
1 quarter
TTD icon
3395
CALL
Trade Desk
TTD
$7.41B
$18.3K ﹤0.01%
1,500
– –
2026 Q1
2 quarters
GERN icon
3396
Geron
GERN
$623M
$17.9K ﹤0.01%
+14,533
New +$20.8K
2026 Q3
0 quarters
LSTA icon
3397
Lisata Therapeutics
LSTA
$13.1M
$17.5K ﹤0.01%
12,183
– –
2025 Q2
5 quarters
FSP icon
3398
Franklin Street Properties
FSP
$41.6M
$17.5K ﹤0.01%
46,408
-23,916
-34% -$10.3K
2023 Q1
14 quarters
CMPX icon
3399
Compass Therapeutics
CMPX
$139M
$17.4K ﹤0.01%
16,764
-64,209
-79% -$132K
2026 Q2
1 quarter
CNTX icon
3400
Context Therapeutics
CNTX
$16.6M
$16.6K ﹤0.01%
55,152
+15,152
+38% +$7.48K
2024 Q3
8 quarters

Similar funds

Cerity Partners's Q3 2026 Portfolio in Review

As of Q3 2026, Cerity Partners held 3,711 positions worth $87.3B, up 5.5% from $82.7B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Cerity Partners's Q3 2026 filing shows 307 new, 1,756 increased, 1,219 reduced and 234 closed positions. Its largest new stake was Vistance Networks Inc: 1,358,996 shares worth $8.13M. The largest sale was Tesla, an estimated $392M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 48% a quarter earlier, followed by Technology and Financials.

  • Cerity Partners's largest Q3 2026 buy was Vistance Networks Inc: 1,358,996 shares worth $8.13M.
  • Cerity Partners added most to State Street SPDR Portfolio S&P 500 ETF in Q3 2026, an estimated $214M increase.
  • Cerity Partners's biggest Q3 2026 reduction was Tesla, cutting an estimated $392M.
  • Cerity Partners fully exited AvalonBay Communities in Q3 2026, selling an estimated $10.6M.
  • Cerity Partners's ten largest holdings make up 25% of its $87.3B portfolio in Q3 2026.
  • Cerity Partners opened 307 new positions and closed 234 in Q3 2026.
  • Cerity Partners's portfolio value rose 5.5% quarter-over-quarter to $87.3B.

Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.